Correlation Between ANT and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both ANT and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANT and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANT and Kymera Therapeutics, you can compare the effects of market volatilities on ANT and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANT with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANT and Kymera Therapeutics.
Diversification Opportunities for ANT and Kymera Therapeutics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ANT and Kymera is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding ANT and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and ANT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANT are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of ANT i.e., ANT and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between ANT and Kymera Therapeutics
Assuming the 90 days trading horizon ANT is expected to generate 5.01 times more return on investment than Kymera Therapeutics. However, ANT is 5.01 times more volatile than Kymera Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 147.00 in ANT on October 20, 2024 and sell it today you would earn a total of 0.00 from holding ANT or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 90.91% |
| Values | Daily Returns |
ANT vs. Kymera Therapeutics
Performance |
| Timeline |
| ANT |
| Kymera Therapeutics |
ANT and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ANT and Kymera Therapeutics
The main advantage of trading using opposite ANT and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANT position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.The idea behind ANT and Kymera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |